FDA considering MDMA-AT for treating PTSD

FDA is considering approving MDMA-AT for treating PTSD, a decision expected by Aug. 11. Veterans have reported positive effects with MDMA therapy. Lawmakers and veterans are advocating for FDA approval despite some concerns from FDA advisory committee.